List of Ephedrine Sulfate drug patents

Ephedrine Sulfate is owned by Endo Ventures.

Ephedrine Sulfate contains Ephedrine Sulfate.

Ephedrine Sulfate has a total of 1 drug patent out of which 0 drug patents have expired.

Ephedrine Sulfate was authorised for market use on 16 October, 2020.

Ephedrine Sulfate is available in solution;intravenous dosage forms.

The generics of Ephedrine Sulfate are possible to be released after 22 January, 2040.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10869845 ENDO VENTURES Ephedrine compositions and methods
Jan, 2040

(16 years from now)

Drugs and Companies using EPHEDRINE SULFATE ingredient

Market Authorisation Date: 16 October, 2020

Treatment: NA


More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in